Clinical Trials Browser

Cytokine Release Syndrome × tocilizumab × 90 days × Clear all

NCT07609940 2026-05-27

POPLIN

Phase 4 Not yet recruiting

Cytokine Release Syndrome, Multiple Myeloma

NCT05972135 2026-04-22

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Multiple Myeloma